State of oncological care for the patients with endometrial cancer in the Republic of Tajikistan
https://doi.org/10.52888/0514-2515-2025-364-1-81-89
Abstract
Aim. To assess the oncological care for patients with endometrial cancer in the Republic of Tajikistan.
Material and methods. he study analyzed statistical data obtained from oncology reporting forms №7 and №35, provided by the Republican Center for Medical Statistics and Information of the Ministry of Health and Social Protection of the Republic of Tajikistan, for the period from 2002 to 2020.
Results and discussion. Over the past decade, a significant increase in endometrial cancer cases has been observed, associated with rising incidence rates and increased life expectancy. Endometrial cancer ranks fourth among malignancies of the female reproductive system, accounting for 10.4% of all cases, and third among all gynecological cancers, accounting for 18.7%.
Conclusion. Over the past decade, there has been a significant 1.5-fold increase in the incidence of endometrial cancer among women in Tajikistan. The rising trend among young women of reproductive age is of particular concern, underscoring the need to implement effective preventive measures and improve early diagnosis. The increasing prevalence of metabolic syndrome, including obesity, adversely affects the incidence, clinical course, and outcomes of patients with endometrial cancer.
About the Authors
S. G. UmarovaTajikistan
N. Z. Muhamadi
Tajikistan
Mukhamadi Nilufari Zokir - researcher
Tel: +992918420692
F. N. Karimova
Tajikistan
References
1. Berlev I.V. Rak endometriya [Endometrial cancer]. Moscow, Eko-vektor Publ., 2017. 263 p.
2. Dzhurabekova K.M. Vliyanie vozrastnogo aspekta i metabolicheskogo sindroma na klinicheskoe techenie raka endometriya [Influence of age and metabolic syndrome on the clinical course of endometrial cancer]. Vestnik Akademii meditsinskikh nauk Tadzhikistana - Bulletin of Academy of medical sciences of Tajikistan, 2019, Vol. 9, No. 2, pp. 133-139.
3. Protasova A.E. Endometrialnyy rak: sovremennye predstavleniya o skrininge [Endometrial cancer: current perspectives on screening]. Kazanskiy meditsinskiy zhurnal – Kazan Medical Journal, 2019, No. 100 (4), pp. 662–672.
4. Ruhl J.L. Cancer Facts & Figures. Atlanta, 2020. (Summary Stage 2018: Codes and Coding Instructions, National Cancer Institute, Bethesda, MD, 2018.)
5. Available at: https://www.cancer.org/cancer/endometrial-cancer/detection-diagnosis-staging/survival-rates.html.
6. Sung H. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. A Cancer Journal for Clinicians, 2021, No. 71 (3), pp. 209-249.
7. Felix A.S. Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences. Advances in Experimental Medicine and Biology, 2017, No. 943, pp. 3-46.
8. Cosgrove C.M. Endometrial Cancer: Who Lives, Who Dies, And Can We Improve Their Story? Oncologist, 2021, Vol. 26 (12), pp. 1044-1051.
9. Njoku K. Endometrial cancer prevention in highrisk women. Best Practice & Research Clinical Obstetrics and Gynaecology, 2019, No. 65, pp. 66-78.
10. Harrison R. Body mass index and attitudes towards health behaviors among women with endometrial cancer before and after treatment. International journal of gynecological cancer: official journal of the International Gynecological Cancer Society, 2020, No. 30 (2), pp. 187-192.
11. Wild C.P, Weiderpass E, Stewart B.W. World Cancer Report: Cancer Research for Cancer Prevention. France, 2020.
12. Available at: http://publications.iarc.fr/586.
13. Mutch D. FIGO Update: Vancouver, Canada. Gynecology and Oncology, 2016, No. 140, pp. 6-7.
Review
For citations:
Umarova S.G., Muhamadi N.Z., Karimova F.N. State of oncological care for the patients with endometrial cancer in the Republic of Tajikistan. Health care of Tajikistan. 2025;(1):81-89. (In Russ.) https://doi.org/10.52888/0514-2515-2025-364-1-81-89